Optymal Technologiessp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2015-06-26
Share capital
5,000.00 PLN
Registered address
ul. Naramowicka 217 B/17, 61-611 Poznań, Poland
Financials
Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 929 days for 2021).
- 2024not filed
- 202329/01/2025
- 202229/01/2025
- 202129/01/2025
- 202004/05/2021
- 201904/05/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Agnieszka Dorota Dopierałaage 52 – President
Manner of representation
Each member of the management board is authorized independently to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| GenxoneS.A. | $665,361.35 | genxone.eu | ||
| Polbiotech Laboratoriumsp. z o.o. | $645,943.81 | polbiotech.pl | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| Relvosp. z o.o. | $120,693.26 | relvo.pl | ||
| Microblicsp. z o.o. | $122,383.50 | microblic.pl | ||
| Xenstatssp. z o.o. | $66,774.27 | xenstats.com | ||
| Detoxedsp. z o.o. | $11,972.37 | detoxed.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Dystrogen TherapeuticsS.A. | – | dystrogen.com | ||
| MIMO BiotechP.S.A. | – | mimobiotech.com |
Change history
| Date | Event | |
|---|---|---|
| 2020-01-22 | Address change (Ul. Kirchholmska 2, 60-288, Poznań → Ul. Naramowicka 217 B/17, 61-611, Poznań) | |
| 2015-06-26 | Entered in the register |
FAQ
The main business activity of Optymal Technologies focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on June 26, 2015.
The headquarters is located at: ul. Naramowicka 217 B, 61-611 Poznań.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
Last updated: 2026-10-07